Literature DB >> 20593406

Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomas.

Maria A Lopez-Garcia1, Felipe C Geyer, Rachael Natrajan, Bas Kreike, Alan Mackay, Anita Grigoriadis, Jorge S Reis-Filho, Britta Weigelt.   

Abstract

Tubular carcinoma (TC) is an uncommon special type of breast cancer characterized by an indolent clinical course. Although described as part of a spectrum of related lesions named 'low-grade breast neoplasia family' due to immunophenotypical and genetic similarities, TCs, low-grade invasive ductal carcinomas of no special type (IDC-NSTs), and classic invasive lobular carcinomas (ILCs) significantly differ in terms of histological features and clinical outcome. The aim of this study was to investigate whether pure TCs constitute an entity distinct from low-grade IDC-NSTs and from classic ILCs. To define the transcriptomic differences between TCs and IDC-NSTs and ILCs whilst minimizing the impact of histological grade and molecular subtype on their profiles, we subjected a series of grade- and molecular subtype-matched TCs and IDC-NSTs and molecular subtype-matched TCs and classic ILCs to genome-wide gene expression profiling using oligonucleotide microarrays. Unsupervised and supervised analysis revealed that TCs are similar at the transcriptomic level to grade- and molecular subtype-matched IDC-NSTs. However, subtle yet significant differences were detected and validated by quantitative reverse transcriptase-PCR, which may in part explain the reported more favourable outcome of TCs. Transcriptomic differences between TCs and molecular subtype-matched classic ILCs were more overt, predominantly due to lower expression of proliferation and cell cycle genes in TCs and down-regulation of cell adhesion/extracellular matrix-related genes in classic ILCs. Our results support the existence of a 'low-grade breast neoplasia family'; however, the transcriptomes of these lesions display small, yet important differences, which, together with their distinct biological behaviour, warrant their separation as discrete entities.

Entities:  

Mesh:

Year:  2010        PMID: 20593406     DOI: 10.1002/path.2743

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  15 in total

1.  Clinicopathologic characteristics and prognosis for molecular subtypes in low-grade breast carcinoma: comparison with grade one invasive ductal carcinoma-not otherwise specified.

Authors:  Shuling Wang; Weidong Li; Ning Liu; Tongxian Zhang; Han Liu; Junjun Liu; Fen Liu; Wei Zhang; Estifanos P Gebreamlak; Yun Niu
Journal:  Med Oncol       Date:  2012-02-07       Impact factor: 3.064

Review 2.  Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way.

Authors:  Nuket Eliyatkın; Evrim Yalçın; Baha Zengel; Safiye Aktaş; Enver Vardar
Journal:  J Breast Health       Date:  2015-04-01

3.  Invasive cribriform carcinoma in a Chinese population: comparison with low-grade invasive ductal carcinoma-not otherwise specified.

Authors:  Wei Zhang; Tongxian Zhang; Zhichun Lin; Xuebao Zhang; Fen Liu; Yahong Wang; Han Liu; Yiling Yang; Yun Niu
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

4.  Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma.

Authors:  Julie M Jorns; Dafydd G Thomas; Patrick N Healy; Stephanie Daignault; Tammi L Vickery; Jacqueline E Snider; Elaine R Mardis; Sherri R Davies; Matthew J Ellis; Daniel W Visscher
Journal:  Arch Pathol Lab Med       Date:  2014-11       Impact factor: 5.534

5.  The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis.

Authors:  Gulisa Turashvili; Edi Brogi; Monica Morrow; Clifford Hudis; Maura Dickler; Larry Norton; Hannah Y Wen
Journal:  Breast Cancer Res Treat       Date:  2017-06-03       Impact factor: 4.872

6.  Risk factors for specific histopathological types of postmenopausal breast cancer in the NIH-AARP Diet and Health Study.

Authors:  Sarah J Nyante; Cher M Dallal; Gretchen L Gierach; Yikyung Park; Albert R Hollenbeck; Louise A Brinton
Journal:  Am J Epidemiol       Date:  2013-06-13       Impact factor: 4.897

7.  Immunophenotypic and genomic characterization of papillary carcinomas of the breast.

Authors:  Raphaëlle Duprez; Paul M Wilkerson; Magali Lacroix-Triki; Maryou B Lambros; Alan MacKay; Roger A'Hern; Arnaud Gauthier; Vidya Pawar; Pierre-Emanuel Colombo; Frances Daley; Rachael Natrajan; Eric Ward; Gaëtan MacGrogan; Flavie Arbion; Patrick Michenet; Britta Weigelt; Anne Vincent-Salomon; Jorge S Reis-Filho
Journal:  J Pathol       Date:  2011-12-09       Impact factor: 7.996

Review 8.  A pure invasive cribriform carcinoma of the breast with bone metastasis if untreated for thirteen years: a case report and literature review.

Authors:  Wei Zhang; Zhichun Lin; Tongxian Zhang; Fen Liu; Yun Niu
Journal:  World J Surg Oncol       Date:  2012-11-20       Impact factor: 2.754

9.  Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry.

Authors:  Britta Weigelt; Jorge S Reis-Filho
Journal:  Breast Cancer Res       Date:  2010-12-20       Impact factor: 6.466

10.  Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial.

Authors:  E Munzone; A Giobbie-Hurder; B A Gusterson; E Mallon; G Viale; B Thürlimann; B Ejlertsen; G MacGrogan; F Bibeau; G Lelkaitis; K N Price; R D Gelber; A S Coates; A Goldhirsch; M Colleoni
Journal:  Ann Oncol       Date:  2015-09-19       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.